中邮证券指出，基础化工行业盈利持续处于底部区间，主要受成本端供需偏紧与商品端供需宽松的双重 影响。近期草酸、甲酸等产品因出口需求增加及供应收缩价格显著上涨。行业整体估值处于历史低位 （PB为1.94倍），叠加美国制造业库存回升及国内房地产政策刺激预期，内外需有望改善。新材料领域 关注国产替代主线，包括特种气体、电子化学品等方向。 新材料50ETF（159761）跟踪的是新材料指数（H30597），该指数从市场中选取涉及先进基础材料、关 键战略材料以及前沿新材料等领域的上市公司证券作为指数样本，以反映新材料产业相关上市公司证券 的整体表现。成分股通常具备较高的科技含量和成长性，代表了中国新材料产业的发展水平与未来方 向。 没有股票账户的投资者可关注国泰中证新材料主题ETF发起联接A（014908），国泰中证新材料主题 ETF发起联接C（014909）。 8月11日午后，新材料50ETF（159761）涨超2.2%。 注：如提及个股仅供参考，不代表投资建议。指数/基金短期涨跌幅及历史表现仅供分析参考，不预示 未来表现。市场观点随市场环境变化而变动，不构成任何投资建议或承诺。文中提及指数仅供参考，不 构成任何投资建 ...

Investment Rating - The report initiates coverage with a "Buy" rating for the company [5][6]. Core Views - The impact of the aortic stent price adjustment is gradually diminishing, and the company maintains its long-term growth potential. The company is positioned in a high-growth segment of high-value consumables [5][6]. - The company has completed over half of its annual equity incentive targets, reflecting confidence in future growth [6][37]. - The company is expanding its product offerings, with new products expected to drive revenue growth in the peripheral intervention segment [10][20]. Company Overview - The company focuses on the research, production, sales, and service of aortic and peripheral vascular interventional medical devices. As of September 2024, its products are used in over 2,400 hospitals in China and have entered 40 countries, saving over 330,000 lives globally [4][20]. - The company has a total market capitalization of 138 billion yuan and a total share capital of 1.23 billion shares [3]. Financial Performance - The company expects revenues of 1.519 billion yuan, 1.894 billion yuan, and 2.331 billion yuan for 2025, 2026, and 2027, respectively, with year-on-year growth rates of 26%, 25%, and 23% [5][12]. - The projected net profit attributable to the parent company for the same years is 617 million yuan, 737 million yuan, and 904 million yuan, with growth rates of 23%, 20%, and 23% [5][12]. - The company’s PE ratios for 2025, 2026, and 2027 are projected to be 22.27, 18.72, and 15.25, respectively [5][12]. Product Development - The company has launched new products, including the Cratos branched stent, which is expected to enhance market acceptance and replace older models [7][10]. - The company is set for a significant year in 2025 for the release of new peripheral products, which are anticipated to become a new growth engine [10][20]. Market Position - The company holds a leading position in the domestic market for aortic interventional products, with a market share of 29% as of 2021 [20]. - The company’s aortic intervention stent revenue has shown a compound annual growth rate (CAGR) of 39% from 2016 to 2023 [20][26].

Investment Rating - The report maintains an "Accumulate" rating for the company [6][7]. Core Viewpoints - The company has benefited from significant growth in high-end products, with a 213% quarter-on-quarter increase in net profit for Q2 2025. The first half of 2025 saw revenue of 2.305 billion yuan, a year-on-year increase of 43.06%, and a net profit of 87 million yuan, up 57.69% year-on-year [2][13]. - The company's M8 grade materials are now in small-batch production for AI servers, and the gross margin for copper-clad laminates increased by 1.78 percentage points year-on-year in the first half of 2025 [3][4]. - The company is positioned as a leading domestic copper-clad laminate manufacturer, with a market share of approximately 3.2% globally, and is expected to benefit from the domestic substitution process [6]. Financial Summary - Revenue projections for the company are as follows: 2,983 million yuan in 2023, 3,362 million yuan in 2024, 4,774 million yuan in 2025, 6,180 million yuan in 2026, and 7,591 million yuan in 2027, with growth rates of -21.1%, 12.7%, 42.0%, 29.4%, and 22.8% respectively [1]. - The net profit attributable to the parent company is projected to be -129 million yuan in 2023, 50 million yuan in 2024, 253 million yuan in 2025, 511 million yuan in 2026, and 821 million yuan in 2027, with year-on-year growth rates of -387.9%, 138.9%, 403.6%, 101.7%, and 60.7% respectively [1]. - The company’s return on equity (ROE) is expected to improve from -5.3% in 2023 to 20.7% in 2027 [1]. Product and Market Development - The company has achieved significant sales growth in its main products, with revenue from copper-clad laminates reaching 1.78 billion yuan in the first half of 2025, a year-on-year increase of 41.88% [3]. - The company is expanding its production capacity, with plans to reach nearly 4 million sheets per month by the end of 2025, supported by new factories in Shanghai, Jiangxi, Jiangsu, and Thailand [5]. - The company is actively involved in various high-performance product sectors, including 5G, cloud computing, AI, and automotive applications [3][4].

注：如提及个股仅供参考，不代表投资建议。指数/基金短期涨跌幅及历史表现仅供分析参考，不 预示未来表现。市场观点随市场环境变化而变动，不构成任何投资建议或承诺。文中提及指数仅供参 考，不构成任何投资建议，也不构成对基金业绩的预测和保证。如需购买相关基金产品，请选择与风险 等级相匹配的产品。基金有风险，投资需谨慎。 新材料50ETF（159761）跟踪的是新材料指数（H30597），该指数聚焦于新材料产业，从市场中选 取涉及先进基础材料、关键战略材料及前沿新材料等领域的上市公司证券作为指数样本，涵盖金属、化 工、建材等行业中具有技术创新和高成长性的企业，以反映新材料相关上市公司证券的整体表现和市场 趋势。 没有股票账户的投资者可关注国泰中证新材料主题ETF发起联接A（014908），国泰中证新材料主 题ETF发起联接C（014909）。 天风证券指出，新材料行业面临下游需求高景气和国产替代机遇，龙头公司凭借高技术壁垒有望迎 来快速成长期。当前光伏玻璃市场成交良好，库存持续下降，组件企业备货积极，8月订单价格预计小 幅上调；电子纱市场刚需支撑稳定，高端产品货源趋紧，需求表现相对良好。玻纤价格处于相对低位， 后续风电 ...

Group 1 - The report highlights that China's exports in July 2025 increased by 7.2% year-on-year, exceeding expectations, driven by factors such as tariff exemptions and fiscal expansion in Europe [8][31] - The Producer Price Index (PPI) in July 2025 showed a month-on-month decline of 0.2% and a year-on-year decrease of 3.6%, indicating a need for stronger domestic demand despite the export growth [8][12] - The domestic machinery equipment sector experienced significant growth, with excavator sales in July 2025 increasing by 25.2% year-on-year, supported by infrastructure investments and projects like the Yajiang Hydropower Station [17][18] Group 2 - The report notes that the consumer price index (CPI) remained flat at 0.0% year-on-year in July 2025, with service prices performing well, contributing to a rise in core CPI [12][14] - The semiconductor industry is witnessing a recovery, with demand for AI-related products and components driving growth, while capital expenditures from North American cloud companies continue to rise [36][41] - The insurance sector is moving towards high-quality sustainable development, with new regulations promoting a balance between accessibility and commercial viability in urban commercial health insurance [25][26]

Investment Rating - The report emphasizes the importance of financial support for the integrated circuit industry as a key focus of national policy, indicating a positive investment outlook for this sector [1][2]. Core Insights - The integrated circuit industry is prioritized in the new industrialization strategy, reflecting its critical role in China's economic transformation and technological independence [1][2][5]. - The report highlights the structural challenges faced by traditional manufacturing and the need for targeted financial support to foster innovation and competitiveness in emerging industries [2][5][6]. - The introduction of the "Guiding Opinions on Financial Support for New Industrialization" aims to address the mismatch between long-term funding needs and short-term financing supply in the manufacturing sector, particularly for integrated circuits [8][9][15]. Summary by Sections Policy Context - The issuance of the financial support policy marks a significant step in implementing the new industrialization strategy, particularly during a period of economic transition and external challenges [2][5]. - The policy aims to enhance the financial ecosystem for key industries, with a specific focus on integrated circuits, to ensure sustainable development and resilience against risks [8][9]. Industry Overview - The global semiconductor market is projected to reach USD 620.2 billion in 2024, with China accounting for 30.1% of the market share, while U.S. companies hold 50% [9]. - Domestic companies have made progress in areas like 5G and AI chips, but overall market share remains below 20% [9][15]. - The report notes that the domestic semiconductor materials and equipment market is experiencing strong growth, driven by policy support and the need for supply chain security [9][11]. Financial Trends - In the first half of 2025, the semiconductor sector saw 395 financing events totaling CNY 27.553 billion, indicating a growing interest from investors in this strategic industry [18][19]. - The report highlights the role of the Science and Technology Innovation Board in facilitating IPOs for semiconductor companies, enhancing capital efficiency and industry impact [18][19]. Challenges and Opportunities - The integrated circuit industry faces significant challenges, including technological gaps with international leaders in advanced semiconductor equipment and processes [16][17]. - The report emphasizes the need for coordinated efforts between government and industry to overcome these challenges and achieve breakthroughs in technology and production capabilities [15][16].

Core Viewpoint - The article emphasizes the positive outlook on the investment market, particularly in sectors supported by government policies, such as consumption, technology innovation, and healthcare [2][3][7]. Group 1: Monetary Policy and Investment Opportunities - The focus of monetary policy will be on enhancing policy transmission, reducing overall financing costs, and promoting the use of structural monetary policy tools [2]. - There is an expectation for continued policy support to boost consumption, which is anticipated to enhance consumer confidence and create opportunities in the consumption sector [2][3]. Group 2: High-Quality Growth Sectors - HSBC maintains a positive view on A-shares, particularly favoring high-quality growth sectors, with significant profit growth expected in AI infrastructure and applications by 2025 [3][4]. - The acceleration of cloud business revenue is anticipated due to the deepening trend of domestic substitution and the further integration of AI into core business operations [4]. Group 3: New Consumption Trends - Strong growth in retail sales has been observed in home appliances and furniture, with year-to-date increases of 30.7% and 22.9% respectively, driven by policies like the old-for-new subsidy [5]. - The rise of new consumption trends, particularly among the Z generation, is reshaping the market, with this demographic expected to quadruple their consumption scale to 16 trillion yuan by 2035 [5]. Group 4: Regional Market Outlook - HSBC maintains an optimistic view on Asian markets, particularly in healthcare, while advising caution due to the uncertain global investment landscape [6][7]. - The firm has a positive outlook on markets in China, India, and Singapore, while holding a neutral stance on Japan, reflecting strong economic and corporate earnings momentum [8].

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company achieved a revenue of 461 million yuan in the first half of 2025, representing a year-on-year increase of 16.46%. The net profit attributable to shareholders was 127 million yuan, up 31.52% year-on-year, driven by increased sales and lower raw material and energy costs [5][8] - The company is expected to grow rapidly, with projected revenues of 1.026 billion yuan, 1.226 billion yuan, and 1.467 billion yuan for 2025, 2026, and 2027 respectively, alongside net profits of 227 million yuan, 272 million yuan, and 324 million yuan for the same years [10][11] Financial Performance - In Q2 2025, the company reported a revenue of 262 million yuan, a year-on-year increase of 33.03%, and a net profit of 86 million yuan, up 40.34% year-on-year [6][15] - The gross profit margin for the first half of 2025 was 46.92%, an increase of 7.24 percentage points year-on-year, while the net profit margin was 27.50%, up 3.15 percentage points year-on-year [5][8] Product Performance - The sales of titanium-silicon series catalysts and pyridine catalysts contributed significantly to revenue growth in the first half of 2025, with the special molecular sieve and catalyst series generating 413 million yuan in revenue, a year-on-year increase of 19.53% [7][10] - The non-molecular sieve catalyst series, however, saw a revenue decline of 39.75%, generating 29 million yuan [7] Research and Development - The company invested approximately 23.44 million yuan in R&D in the first half of 2025, reflecting an increase of 11.43% year-on-year, focusing on enhancing product innovation and upgrading core technologies [9][10] Market Position and Strategy - The company is positioned as a leading domestic catalyst manufacturer, with a focus on expanding its product offerings and enhancing its competitive edge through vertical and horizontal integration strategies [10][11] - The company has successfully completed trial production of several projects, including special molecular sieves and environmental catalysts, which are expected to contribute to future revenue growth [10]

Group 1 - The software ETF (515230) rose over 1.3% on August 11, indicating positive market sentiment towards the software sector [1] - Debon Securities highlighted that the explosive growth in token processing for large models may lead to a gradual closure of AI business models, with domestic computing power demand expected to rise further [1] - Major overseas companies are experiencing simultaneous growth in performance and capital expenditure, with the computing power industry chain maintaining high prosperity, as companies significantly increase investments in AI infrastructure [1] Group 2 - Meta plans to increase its capital expenditure to between $66 billion and $72 billion by 2025, reflecting the industry's focus on enhancing computing power [1] - The upgrade in computing power is driving improvements in chip bandwidth density and energy consumption density, with liquid cooling and higher-spec optical modules entering a phase of significant performance growth [1] - Domestic policies are supporting AI development, with the "Artificial Intelligence +" initiative approved by the State Council and local governments implementing measures such as issuing computing power vouchers in Shanghai [1] Group 3 - The security issues surrounding Nvidia's computing power chips have accelerated the push for domestic alternatives, with the National Cyberspace Administration having discussions with Nvidia regarding vulnerability risks [1] - The industry is experiencing strong growth driven by technological iterations, policy support, and domestic substitution [1] - The software ETF (515230) tracks the software index (H30202), which selects listed companies involved in application software, system software, and technical services to reflect the overall performance of the software industry [1]

截至2025年8月11日 11:15，科创100ETF基金(588220)上涨2.15%，跟踪指数成分股东芯股份(688110)上 涨19.12%，峰岹科技(688279)上涨8.74%，南微医学(688029)上涨7.41%，生益电子(688183)、威迈斯 (688612)等个股跟涨。 近期科创板块迎来整体性反弹，短期驱动来自两方面：一是海外算力标的打开上涨空间，叠加美国人工 智能计划落地，进一步强化国产替代逻辑；二是AI产业链催化持续，GPT-5.0、DeepSeek R2等新模型预 期形成有效支撑。 科创100ETF基金(588220)，场外联接A：019861；联接C：019862；联接I：022845。 数据显示，截至2025年7月31日，上证科创板100指数(000698)前十大权重股分别为博瑞医药(688166)、 百济神州(688235)、华虹公司(688347)、睿创微纳(688002)、翱捷科技(688220)、泽璟制药(688266)、东 芯股份(688110)、中科飞测(688361)、芯源微(688037)、安集科技(688019)，前十大权重股合计占比 23.52%。 科创100 ...